Search - tctmd.com

Displaying 81 - 100 of 1596

Sort: Relevancy | Date

TITRATE-HF: Use of GDMT for HF Is Getting Better but Still Not Ideal

Todd Neale

May 21, 2025

News Daily News

Registry Data Rekindle Talk Over the Best Valve for TAVI in Small Annuli

Caitlin E. Cox

May 19, 2025

News Daily News

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

L.A. McKeown

May 16, 2025

News Daily News

Procedural MIs Have Little Effect on Quality of Life: ISCHEMIA

Yael L. Maxwell

May 15, 2025

News Conference News European Congress on Obesity 2025

Obesity-Related Cancer Rates No Different With GLP-1s vs Bariatric Surgery

Michael O'Riordan

May 14, 2025

News Daily News

CV Death Rates in Autoimmune Disorders Waning, but Still Higher in Women

L.A. McKeown

May 14, 2025

News Conference News European Congress on Obesity 2025

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

Michael O'Riordan

May 13, 2025

News Conference News European Congress on Obesity 2025

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Michael O'Riordan

May 12, 2025

News Conference News EAS 2025

Back From the Brink: Obicetrapib Performs Well in BROADWAY, TANDEM

Yael L. Maxwell

May 08, 2025

News Daily News

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Michael O'Riordan

May 07, 2025

News Conference News SCAI 2025

BATMAN Signals New Way to Prevent LVOT Obstruction in High-Risk TMVR Patients

L.A. McKeown

May 07, 2025

News Conference News HRS 2025

BIO-LIBRA: Outcomes Vary by Sex, Device in Cardiomyopathy Patients With ICDs

Todd Neale

May 02, 2025

News Daily News

Access to GLP-1 Drugs Unequal for US Patients With Obesity

Caitlin E. Cox

May 01, 2025

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

L.A. McKeown

April 18, 2025

News Daily News

Black Adults Face CV Mortality Beyond Their Predicted Risk

Caitlin E. Cox

April 18, 2025

News Daily News

High-Sensitivity Troponin Tests Might Aid in Primary Prevention

Yael L. Maxwell

April 16, 2025

News Daily News

Topline Data Point to Promise for VERVE-102 Gene-Editing Therapy

Caitlin E. Cox

April 14, 2025

News Conference News ACC 2025

ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a)

L.A. McKeown

April 10, 2025

News Conference News EHRA 2025

Post-TAVI Pacemaker Tied to Poorer Long-term Outcomes

Todd Neale

April 08, 2025

Advertisement

TITRATE-HF: Use of GDMT for HF Is Getting Better but Still Not Ideal

Registry Data Rekindle Talk Over the Best Valve for TAVI in Small Annuli

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

Procedural MIs Have Little Effect on Quality of Life: ISCHEMIA

Obesity-Related Cancer Rates No Different With GLP-1s vs Bariatric Surgery

CV Death Rates in Autoimmune Disorders Waning, but Still Higher in Women

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Back From the Brink: Obicetrapib Performs Well in BROADWAY, TANDEM

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

BATMAN Signals New Way to Prevent LVOT Obstruction in High-Risk TMVR Patients

BIO-LIBRA: Outcomes Vary by Sex, Device in Cardiomyopathy Patients With ICDs

Access to GLP-1 Drugs Unequal for US Patients With Obesity

April 2025 Dispatch for the CV Team

Black Adults Face CV Mortality Beyond Their Predicted Risk

High-Sensitivity Troponin Tests Might Aid in Primary Prevention

Topline Data Point to Promise for VERVE-102 Gene-Editing Therapy

ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a)

Post-TAVI Pacemaker Tied to Poorer Long-term Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content